Genetics of fibrin clot structure: A twin study

Blood

Volumn 103, Issue 5, 2004, Pages 1735-1740

  Dunn, Emma J ^b   Ariëns, Robert A ^b   De Lange, Marlies ^b   Snieder, Harold ^b   Turney, John H ^b   Spector, Timothy D ^b   Grant, Peter J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13B; FIBRIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONFIDENCE INTERVAL; CORONARY ARTERY THROMBOSIS; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; FIBRIN CLOT; GENETIC ANALYSIS; HEART INFARCTION; HERITABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; TURBIDITY; UNITED KINGDOM;

EID: 1442283453     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2247     Document Type: Article

References (44)

1. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041-1046.
2. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA. 1987;258:1183-1186.
3. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
4. Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost. 1998;79:129-133.
5. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351-355.
6. de Lange M, Snieder H, Ariëns RAS, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet. 2001;357:101-105.
7. Cesari M, Sartori MT, Patrassi GM, Vettore S, Rossi GP. Determinants of plasma levels of plasminogen activator inhibitor-1: a study of normotensive twins. Arterloscier Thromb Vasc Biol. 1999;19:316-320.
8. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985;37:89-101.
9. Souto JC, Almasy L, Borrell M, et al. Genetic determinants of haemostasis phenotypes in Spanish families. Circulation. 2000;101:1546-1551.
10. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000. 95:1517-1532.
11. Nair CH, Azhar A, Dhall DP. Studies of fibrin network structure in human plasma, I: methods for clinical application. Thromb Res. 1991;64:455-476.
12. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96-110.
13. Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariëns RAS. Functional analysis of the fibrinogen Aα Thr312Ala polymorphism: effects on fibrin structure and function. Circulation. 2003;107:2326-2330.
14. Ariëns RAS, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The Factor XIII Val34leu polymorphism accelerates thrombin activation of Factor XIII, and affects cross-linked fibrin structure. Blood. 2000;96:988-995.
15. Ariëns RAS, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol. 1999;19:2012-2016.
16. Mills JD, Ariëns RAS, Mansfield MW, Grant PJ. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002;106:1938-1942.
17. Weisel JW, Nagaswami C. Computer modelling of fibrin polymerisation kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J. 1992;63:111-128.
18. Kyvik KO. Generalisability and assumptions of twin studies. In: Spector TD, Snieder H, MacGregor AJ, eds. Advances in Twin and Sib-Pair Analysis. London, England: Greenwich Medical Media; 2000:67-77.
19. Falconer DS. Introduction to quantitative genetics. 3rd ed. Harlow, England: Longman; 1989.
20. Neale MC, Cardon LR. Methodologies for Genetic Studies of Twins and Families. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1992.
21. Spector TD, Snieder H, MacGregor AJ. Advances in Twin and Sib-Pair Analysis. London, England: Greenwich Medical Media Ltd; 2000.
22. Neale MC, Boker SM, Xie G, et al. Mx: statistical modelling [computer program]. 5th ed. Richmond, VA: University of Virginia Department of Psychiatry, 1995.
23. Lim BCB, Ariëns RAS, Carter AM, Weisel JW, Grant PJ. Genetic regulation of fibrin structure and function: complex gene environment interactions may modulate vascular risk. Lancet. 2003;361:1424-1431.
24. Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of clot rheology. Biophys J. 1999;77:2813-2826.
25. MacGregor SJ, Snieder H, Schork NJ, Spector TD. Twins: novel uses to study complex traits and genetic disease. Trends Genet. 2000;16:131-134.
26. Spector TD, MacGregor AJ. The St. Thomas' UK Adult Twin Registry. Twin Res. 2002;5:440-443.
27. Reynolds CA, Hewitt JK. Issues in the behavioral genetic investigation of gender differences. In: Turner JR, Cardon LR, Hewitt JK, eds. Behavior genetic approaches in behavioral medicine. New York, NY: Plenum; 1995:189-199.
28. Mansfield MW, Kohler HP, Ariëns RAS, McCormack LJ, Grant PJ. Circulating levels of coagulation factor XIII in subjects with type II diabetes and in their first-degree relatives. Diabetes Care. 2000;23:703-705.
29. Ichinose A, Davie EW. Primary structure of human coagulation factor XIII. Adv Exp Med Biol. 1988;231:15-27.
30. Cooper AV, Standeven KF, Ariëns RAS. Fibrinogen gamma chain splice variant γ alters fibrin formation and structure. Blood. 2003;102:535-540.
31. Siebenlist KR, Meh DA, Mossesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing chains. Biochemistry. 1996;35:10448-10453.
32. Greilich PE, Carr ME, Zekert SL, Dent RM, Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease. Am J Med Sci. 1994;307:15-20.
33. Jörneskog G, Egberg N, Fagrell B, et al. Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia. 1996;39:1519-1523.
34. Fatah K, Silveira A, Tornvall P, Karpe F, Blombäck M, Hamsten A. Proneness to tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost. 1996;76:535-540.
35. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem. 1992;287:24259-25283.
36. Carr ME Jr, Alving BM. Effect of fibrin structure on plasmin mediated dissolution of plasma clots. Blood Coagul Fibrinolysis. 1995;8:587-573.
37. Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc. Biol. 2000;20:1354-1381.
38. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. Genetic contribution to circulating levels of haemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arterioscler Thromb Vasc Biol. 2002;22:506-510.
39. Ariëns RAS, de Lange M, Snieder H, Spector TD, Grant PJ. Activation markers of coagulation and flbrinolysis in twins: heritability of the prethrombotic state. Lancet. 2002;359:667-671.
40. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Heart Study. N Engl J Med. 1990;322:1635-1641.
41. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke and other cardiovascular dlseases in the United States: findings of the national conference on cardiovascular disease preventlon. Circulation. 2000;102:3137-3147.
42. Hammar N, Kaprio J, Hagstrom U, Alfredsson L, Koskenvuo M, Hammar T. Migration and mortality: a 20-year follow-up of Flnnish twin pairs with migrant co-twins in Sweden. J Epidemiol Community Health. 2002;58:362-366.
43. Hsu-Hage BH, Wahlqvist ML. Cardiovascular risk in adult Melbourne Chinese. Aust J Public Health. 1993;17:306-313.
44. Marmot MG, Syme SL, Kagan A, Kato H, Cohen JB, Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol. 1975;102:514-525.